SCHEDULE 13D/A: Rosalind Advisors and Affiliates Maintain Significant Stake in Delcath Systems, Appointing Key Directors

An amendment to a Schedule 13D filing reveals Rosalind Advisors and its affiliated funds continue to hold a substantial beneficial ownership in Delcath Systems, with key personnel Steven Salamon and Gil Aharon serving as independent directors on the company's board.

Summary

• Rosalind Advisors, Inc., Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P., Steven Salamon, and Gil Aharon are the reporting persons in this Schedule 13D/A filing.
• Rosalind Advisors, Inc. beneficially owns 6,674,993 shares, representing 9.9% of Delcath Systems' common stock.
• Steven Salamon beneficially owns 162,379 shares with sole voting/dispositive power and 6,401,550 shares with shared voting/dispositive power, totaling 9.9% beneficial ownership.
• Gil Aharon beneficially owns 111,064 shares with sole voting/dispositive power and 6,401,550 shares with shared voting/dispositive power, totaling 9.9% beneficial ownership.
• Rosalind Master Fund L.P. beneficially owns 2,871,335 shares with shared voting/dispositive power, representing 4.5% of the class.
• Rosalind Opportunities Fund I L.P. beneficially owns 3,530,215 shares with shared voting/dispositive power, representing 5.0% of the class.
• All beneficial ownership percentages are subject to 'Blockers': a 9.99% Preferred Stock Blocker and a 4.99% Warrant Blocker, preventing conversion or exercise beyond these thresholds.
• As of May 6, 2025, Delcath Systems had 34,826,183 shares of Common Stock issued and outstanding.
• Steven Salamon and Gilad Aharon were elected as independent directors to Delcath Systems' Board of Directors on May 6, 2020, increasing the board size to eight members.
• Mr. Salamon was elected as a Class III director with a term expiring at the 2024 Annual Meeting of Stockholders.
• Dr. Aharon was elected as a Class I director with a term expiring at the 2025 Annual Meeting of Stockholders.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While the document is primarily a regulatory disclosure, the continued significant beneficial ownership by Rosalind entities and the presence of their key personnel on the board suggest ongoing investor confidence and potential for strategic influence. The 'blockers' are a limiting factor for the investors, but not necessarily negative for the company itself.

Positives

• The appointment of Steven Salamon and Gilad Aharon as independent directors provides significant representation for a major investor group on the company's board, potentially aligning management interests more closely with those of these shareholders.
• The increase in board size to eight members may indicate a strategic expansion of governance and oversight capabilities.

Risks

• The 'Preferred Stock Blockers' limit the Reporting Persons from converting their Preferred Stock if it would result in beneficial ownership exceeding 9.99% of the outstanding Common Stock.
• The 'Warrant Blockers' limit the Reporting Persons from exercising their Warrants if it would result in beneficial ownership exceeding 4.99% of the outstanding Common Stock.
• These blockers mean the Reporting Persons were not able to exercise all of their Reported Preferred Stock or any of their Reported Warrants as of the filing date, potentially limiting their full economic interest or influence.

Future Outlook

The document primarily details historical beneficial ownership and board appointments, with no explicit forward-looking statements or guidance regarding the company's future performance or strategic direction beyond the terms of the appointed directors.

Industry Context

This filing is a standard disclosure of significant beneficial ownership and board representation, common in situations where an investor group takes an active interest in a company. It does not provide broader industry trends but highlights the ongoing involvement of a specific investment advisory firm in Delcath Systems.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The filing indicates continued significant beneficial ownership by Rosalind entities and their representation on the board, which could be seen as positive for shareholder advocacy and alignment of interests.
• Management: The addition of two independent directors from a major investor group may influence strategic decisions and corporate governance.

Next Steps

• Steven Salamon's term as a Class III director is scheduled to expire at the 2024 Annual Meeting of Stockholders.
• Gilad Aharon's term as a Class I director is scheduled to expire at the 2025 Annual Meeting of Stockholders.

Key Dates

Keywords

Delcath Systems, Rosalind Advisors, Schedule 13D, Beneficial Ownership, Board of Directors, Independent Directors, Shareholder Activism, Preferred Stock, Warrants, Corporate Governance, SEC Filing